Founded Year
2013Stage
Series C | AliveTotal Raised
$30.87MLast Raised
$12.69M | 20 days agoAbout Artax Biopharma
Artax Biopharma is a clinical-stage biopharmaceutical company that develops therapies for autoimmune diseases. Its pipeline of drugs is based on science that targets the interaction between T-cell receptors (TCR) and Nck, a key protein involved in T-cell activation.
Artax Biopharma Headquarter Location
1 Broadway 14th Floor
Cambridge, Massachusetts, 02142,
United States
617-401-2168
Latest Artax Biopharma News
Dec 15, 2021
Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announces...
Expert Collections containing Artax Biopharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Artax Biopharma is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
15,532 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Artax Biopharma Patents
Artax Biopharma has filed 3 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immune system
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/27/2019 | 6/30/2020 | Clusters of differentiation, Immune system, Immunology, Autoimmune diseases, Transcription factors | Grant | |
Application Date | 2/27/2019 | ||
|---|---|---|---|
Grant Date | 6/30/2020 | ||
Title | |||
Related Topics | Clusters of differentiation, Immune system, Immunology, Autoimmune diseases, Transcription factors | ||
Status | Grant |